Article
CD37 high expression as a potential biomarker and association with poor outcome in acute myeloid leukemia
1 May 2020
Abstract excerpt
BACKGROUND: CD37, a member of the transmembrane 4 superfamilies (TM4SF), has been proved to be abnormally expressed in a range of malignancies. Herein, we investigate the effects of CD37 expression and analyze its clinical outcome in acute myeloid leukemia (AML) patients. METHODS: The RNA-seq and clinical data of AML patients were obtained from cBioPortal database. CD37 correlated genes, the expression prolife...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
